MedCity CONVERGE has started its search for 24 of the best startups across healthcare. CONVERGE, an executive summit on July 9-10 in Philadelphia, delivers the most accurate picture of where healthcare innovation is heading because it unites all sectors in healthcare.
So the CONVERGE Startup Showcase will be no different. We’ll bring a collection of early-stage companies from across the life sciences and digital health that have unique ideas to some of the big opportunities in medicine. We’ll recognize them on MedCityNews.com, they’ll get showcase space and be able to network with 500 thought leaders across healthcare. In some cases, Startup Showcase members will participate in the panels or deliver a main-stage demonstration.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
Startups can apply for free spots in the startup showcase from now through May. However, MedCityNews.com’s editorial team will begin making selections and sending out invitations as soon as March. So start applying now.
Applicants should keep in mind the following criteria:
- Selected startups should offer a unique solution to an unmet need in the market and have evidence of traction with their idea
- Digital health companies will have been operating for no more than 18 months with no later than A-round funding
- Life science companies should be no later than A-round funding and/or embarked on a Phase 2 trial
Last year’s attendees included startups like Medivo, which went on to process more than a half-million lab results and get featured in Inc. Magazine, and Zeel, which is booking online appointments throughout the country and was since recognized in places from Forbes to InStyle.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Fill out the form in the Startup Showcase page on the CONVERGE site for your chance to participate.
And don’t miss your chance to see these startups and be part of CONVERGE. Take advantage of our early-bird ticket rate by buying your CONVERGE tickets now. Executives from UnitedHealth Group, AARP, Intel, Janssen Healthcare Innovation, Independence Blue Cross and many others will participate. We’ll have unique and empowering discussions on trends in globalization; best practices in extracting innovation from healthcare; how big med devices and pharma companies are engaging technology and the early stage; and opportunities in areas such as big data, diabetes and telemedicine, among many other topics.
